Company intelligence / Profile preview

Saiba Animal Health

Pfäffikon, Schwyz, Switzerland

Ownership: Private
Development stage: Other

Overview

Saiba Animal Health developed a novel virus-like particle vaccine platform to induce therapeutic immune responses against chronic diseases such as allergy, inflammation, and pain in companion animals. The technology aims for more specific and longer-lasting therapeutic effects than current approaches[1][2].

Therapeutic areas: ImmunologyNeurology
Modalities: VaccineVirus-like particle-based vaccineBiologic
Industry: Veterinary

Partnerships

Boehringer Ingelheim (previous collaborator, now acquirer)[1][2][5][6]

Beyond the preview

Go deeper on Saiba Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saiba Animal Health.

Explore the full profile